Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
In adults with overweight or obesity (without diabetes) the semaglutide 2.4 mg dose produced an average weight reduction of about 15% of baseline body weight over ~68 weeks in the STEP 1 trial, a result that surprised many clinicians because it brought pharmacologic outcomes into a range previously associated with surgical interventions
I feel great and I am maintaining my weight
Final Thoughts If you have read through this blog, you now have a clearer picture of why liposomal glutathione dosage is not a one-size-fits-all number
Clinical trials data showed that some people notice reduced appetite within weeks of starting Wegovy tablets, but meaningful weight loss typically developed over several months
These effects typically improve over time, but its important to report any ongoing or severe symptoms to your provider
